The mayor-elect is about to inherit a messy bankruptcy affecting thousands of rent-stabilized New Yorkers. He’s also ...

Merck’s MRK stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since early November, indicating sustained bullish momentum. The 50-day moving average is a short-term ...

Hollywood titans Paramount and Netflix are locked in a debt-fueled showdown for Warner Bros., powered by Wall Street muscle, ...

The Trump group, the business empire helmed by American President Donald Trump’s family, is set to invest around ₹1 trillion ...

For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole ...

The recent share price jump follows a cash infusion announcement, where 4DMedical secured an underwriting agreement with Bell Potter for the exercise of its listed options, ensuring a capital inflow ...

“The research that’s needed most is the risk stratification research—who do we screen,” says Dr. Gabre. By getting to the ...

Colon cancer is hitting long before the usual screening age. If you could ID who's at risk, you could screen early and save ...

The announcement comes a day after the state government proposed renaming a prominent stretch of road, running alongside the ...

All three dose groups (50 mg, 100 mg and 200 mg) showed impressive monotherapy efficacy, with VGPR+ (very good partial response or better) of ≥70% despite limited follow-up; evidence shows that these ...

The addition of ianalumab to eltrombopag significantly improved outcomes for patients with pretreated primary immune ...

CHENNAI: Microsoft announced today that it will invest US$17.5 billion in India, the company’s largest commitment in Asia to ...